生物疗法缓解了喘和慢性鼻炎与鼻的患者的耳部症状和迹象
Anna Suikkila1, Annina Lyly2, Riitta Saarinen1
1Department of Otorhinolaryngology - Head and Neck Surgery University of Helsinki and Helsinki University Hospital Helsinki Finland.
Laryngoscope investigative otolaryngology
|July 25, 2025
概括
第二种类型的抗炎生物药物显著改善了患有慢性鼻炎与鼻息肉 (CRSwNP) 和喘的患者的耳部症状和症状. 这些发现表明中耳炎 (OM) 可能是生物治疗的目标.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 过敏和免疫学 过敏和免疫学
- 肺部病理学 肺部病理学
背景情况:
- 在患有严重喘和带鼻息肉的慢性鼻炎 (CRSwNP) 的患者中,耳部症状很常见.
- 中耳炎 (OM) 经常与这些患者的异性多病症有关.
- 关于生物制剂对OM症状的影响的研究有限.
研究的目的:
- 研究2型抗炎生物制剂在缓解耳部症状和征兆方面的疗效.
- 探索生物药物在管理OM中作为CRSwNP和喘的并发症的潜力.
主要方法:
- 对生物治疗的CRSwNP患者电子病历的回顾性审查.
- 包括先前对NSAID恶化呼吸道疾病 (NERD) 的研究中的患者.
- 使用经过验证的患者报告的结果测量 (PROMs) 评估耳部症状和迹象,如12个月后的中鼻结果测试-22 (SNOT-22) 和耳部结果调查-16 (EOS-16).
主要成果:
- 观察到耳部症状显著减少,包括耳部充满,头,耳部疼痛和面部疼痛/压力 (p < 0.005).
- 患者报告的结果指标 (SNOT-22和EOS-16) 显示了显著的改善.
- 临床耳部病征也显著改善 (p = 0.003).
结论:
- 用于喘和CRSwNP的生物药物有效地减少了耳部症状和征兆.
- 中耳炎 (OM) 可能是生物干预的新型治疗点.
- 建议进行进一步的前性研究来证实这些发现,并探索OM作为生物治疗的目标.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
Drugs Used in Lower Respiratory Disorders: Overview
589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
397
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
397
COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314
Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
Drugs Used in Upper Respiratory Disorders: Overview
367
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
367


